Navigation Links
NimbleGen to discontinue IPO after Roche's $272.5 million acquisition

Madison, Wis. - NimbleGen Systems, a manufacturer of gene chips for pharmaceutical research, will discontinue its work toward an initial public offering of stock following its acquisition by Roche, the Basel, Switzerland based pharmaceutical giant.

NimbleGen had sought to raise $75 million in the IPO, but und......

Full article >>> ich reported $13.5 million in revenue last year, was spun out of the University of Wisconsin-Madison and has reached this point with the help of venture funding from firms like Baird Venture Partners and Venture Investors. The company pursued an IPO in pa......

Full article >>> potential drug targets.

In addition, NimbleGen plans to expand its product portfolio to include higher-density arrays and integrated instrument systems for advanced genome analysis.

Roche milestone

In 2006, the Roche pharmaceuticals division reported sales of 33.3 billion Swiss francs, and the diagnostics division posted sales of 8.7 billion Swiss francs. The com......

Full article >>> xciting" development for the state's biotechnology industry, noting that state officials have been trying to attract a global pharmaceutical company.

Leonhart cited the state's courting of Abbott Labs, which has acquired 500 acres of land in the Kenosha County communities of Pleasant Prairie and Bristol, but has yet to officially announce whether i......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/19/07


Related biology technology :

1. NimbleGen researcher to lead $415K DNA project
2. IPO-bound NimbleGen traveling in fast company
3. Madison biotech NimbleGen files for IPO; one of states best-funded firms
4. Genomics researcher Hood joins NimbleGen board
5. NimbleGen partners with UK biotech firm
6. NimbleGen extends research market reach
7. NimbleGen microarrays speed genetic findings
8. NimbleGen names CFO with capital-raising past
9. NimbleGen partners with leading researchers
10. NimbleGen closes $8.2m venture round, bringing total to $50m
11. NimbleGen Systems CGS technique helps identify stomach bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
Breaking Biology News(10 mins):